Abstract The H1N1 2009 virus is pandemic in many countries. The genome of this virus contains eight segments. Among the eight segments maximum numbers of mutation occur at the segment 1 and segment 4 which codes for PB2 subunit and hemagglutinin (HA) and less number of mutations occur in segment 6 which codes for neuraminidase (NA) protein. Neuraminidase (NA) inhibitors (Oseltamivir and Zanamivir) are presently used as an anti-fl u drugs. In the present study, the in silico effi cacy of different drugs was tested against the swine fl u virus. 3D structures of neuraminidase (NA) proteins of H1N1 2009 were generated using Geno3D. The 3D structure of H1N1 1918 was downloaded from PDB. Interaction study was done using Arguslab 4 and PyMol view. Oseltamivir and Zanamivir have good number of interactions with H1N1 2009 virus and the scoring function also support to this result. When compared with the 1918 H1N1 viral protein, 2009 H1N1 NA protein shows more number of interaction and good scoring function. The RMSD value of before and after docking are found to be same at 0.04A° for both the drugs. The force fi eld energy of NA protein 2009 was found to be -15603.529 KJ/mol before docking. The force fi eld energy was found to be decreased after docking at -17620.740 KJ/ mol with Tamifl u and -17652.242 KJ/mol with Zanamivir. The number of interaction and scoring function shows that Oseltamivir and Zanamivir will be able to effectively control the present pandemic H1N1 virus 2009.
Introduction
In April 2009, the so called "swine fl u" infl uenza A (H1N1) virus was fi rst identifi ed in Mexico and later it was identifi ed in other American, European, African and Asian countries [1] . This virus is a major pathogen to human but not epidemic in pigs [2] . Infl uenza A viruses are negative sense single-stranded RNA viruses belonging to the family Orthomyxoviridae and possess a genome of eight singlestranded segments. Based on the antigenic properties of its surface glycoproteins, Infl uenza A virus is further classifi ed as hemagglutinin (HA) and neuraminidase (NA). HA is of special interest due to its role in the viral entry mechanism and immune recognition. It consists of two subunits: HA1, which contains the receptor-binding and antigenic domains, and the HA2 subunit, which is responsible for the fusion of the virion with the endosomal membrane in the host cell [2] . All infl uenza viruses contain two surface antigens, namely hemagglutinin (H) and neuraminidase (N) and the viral strains are assigned as HxNx nomenclature based on which the forms of these two proteins are present. There are 16 H and 9 N subtypes known in birds, out of which only H-1, 2 and 3, and N-1 and 2 are commonly found in humans [3] . Out of the 144 total combinatorial possibilities of HAs and NAs only H1N1, H2N2 and H3N2 are human adapted virus [4] . The viral structure differs from strainto-strain due to rapid genetic mutation in the genome. The newly identifi ed strain H1N1 is responsible for swine fl u in humans [3] . Infl uenza A H1N1 viral strain 2009 is a triple re-assortment of infl uenza fl u viral strains: HA, NA, MP, NP and NS (originated from swine infl uenza virus); PB2 and PA (originated from bird infl uenza virus); PB1 (originated from human infl uenza virus) [5, 6] . Antiviral drugs such as M2 channel inhibitors (Amantadine and Rimantadine) and neuraminidase inhibitors (Oseltamivir and Zanamivir) are widely used clinically to control this infl uenza virus. The function of M2 channel in the virus is to mediate an infl ux of H + ions into the infecting virion early in the viral replication cycle, which facilitates the dissociation of the ribonucleoproteins from the virion interior and allows them to be released into the cytoplasm and transported into the cell nucleus [7] . High resistance to M2 channel inhibitors are found in the present H1N1 virus and also it is limited in use [2] . The resistance of M2 channel inhibitor is due to the mutation of S21N in the M2 channel and loss of the Amantadine-binding site [8] . Some of the recent research report shows that Oseltamivir has resistance to the H1N1 virus but Zanamivir still effectively controls the pathogenicity of this virus [7, 8] . The Oseltamivir-resistant viruses are mainly isolated from adult in European swine fl u cases [9] . Oseltamivir and Zanamivir are the neuraminidase inhibitor (NA) [7] . The H274Y substitution in the neuraminidase active site pushes the G276 further into the binding site and disrupts the hydrophobic pocket and leads to the resistance of Oseltamivir [7] . The incidence of infl uenza A (H1N1) viruses that carry the neuraminidase H274Y mutation has increased by 30% in this year in the Netherlands. Infl uenza A (H1N1) virus that carry this mutation is resistant to Oseltamivir but remains sensitive to Zanamivir [7] . But in the present study it is shows that Oseltamivir and Zanamivir will be able to effectively control the present pandemic H1N1 virus 2009.
Materials and methods

Genome analysis
The whole genome of the H1N1 virus (2009) is downloaded from NCBI (http://www.ncbi.nlm.nih.gov/). Genome of H1N1 virus consists of eight segments. The sequences were BLAST in the NCBI tool using New York sequence as representative sequence. From the BLAST result 100 sequences have been selected and multiple sequence alignment was performed using Clustal W in Bioedit. All the nucleotide segments of the genome were translated using GENSCAN (http://genes.mit.edu/GENSCAN.html). The translated protein sequences were run in InterProScan to check the protein signature, biological relevant sites and profi les in protein sequences.
Homology modeling of whole proteins
Comparative modeling is quite useful in predicting the unknown 3D protein structures by both starting from a known primary structure and relying on known 3D structures of homologous proteins. Sequentially related proteins are assumed to adopt similar conformations. The atomic positions in homologous regions are borrowed from known protein structures, while non homologous portions are predicted in various ways, including potential energy minimization, molecular dynamics and simulated annealing. Two most convenient criteria for similarity are: (a) an identity of at least 25% for a sequence size > 100 amino acids and (b) an expectation value (E) < 10 −4 , which gives the likelihood that similarities are due to chance [10] . 
The H1N1 2009 has maximum identity of 90% with H5N1 neuraminidase (PDB id 2HTY). H5N1 NA protein is selected as a template for homology modeling. We used GENO3D an automatic online server to model the 3D structure. The quality of the modeled 3D structure is checked by using ProQ. The energy of the modeled protein was minimized in vacuum.
ArgusLab4/AScore/ShapeDock fl exible docking
The docking problem is considered as a complicated optimization or an exhaustive search problem involving many degrees of freedom. The ultimate goal is to fi nd out the optimal ligand/protein confi gurations with accuracy. At the same time we consistently predict their binding free energy without relying on formal statistical mechanical approaches. The A Score is based on the deconvolution of the total protein-ligand binding free energy. This is having several distinct components:
The dissected terms account for the van der Waals interaction between the ligand and the protein, the hydrophobic effect, the hydrogen bonding between the ligand and the protein, the hydrogen bonding involving charged donor and/or acceptor groups, the deformation effect, and the effects of the translational and rotational entropy loss in the binding process, respectively. The intraligand van der Waals energy is also included in the overall vdW term. These contributions can be conveniently written as the following products:
Each of the contributions possesses a specifi c regression coeffi cient multiplying a term that has aclear physical meaning. By investigating the regression coeffi cients, it enable more profound insights into the receptor-ligand binding process [10] .
The interaction of Oseltamivir and Zanamivir with the infl uenza A virus (H1N1 1918, and H1N1 2009) were studied after docking in Arguslab 4. The protein 3D structure of H1N1 1918 is downloaded from PDB. The 3D structures of 2009 H1N1 NA protein generated by homology modeling was used for docking. The docking results were saved in the PDB format and observed in the PyMol view. From the PyMol view it is able to fi nd out the number of interactions present in the residue and distance of the hydrogen bonds.
Results
The available 2009 H1N1 genome sequence was downloaded from NCBI. It consists of eight nucleotide segment which were translated to eight protein sequences with the help of GENSCAN. These nucleotide sequences of the H1N1 2009 genome were analysed by NCBI-BLAST using New York H1N1 strain 2009 sequence as a representative sequence. BLAST result shows the diversity of different H1N1 virus sequences. By using multiple sequence alignment tool Clustal W these sequences were aligned and results shows that only some of the segments are more susceptible for mutations in the H1N1 virus (2009 as a representative sequence (gi|242032105, gi|242032103, gi|242032101, gi|242032089, gi|242032096, gi|242032094, gi|242032091, gi|242032098). The maximum numbers of mutations are found in segment 1 and segment 4 which codes for PB2 subunit and hemagglutinin. The result of the InterProScan is given in Table 2 . InterProScan scans a range of protein signatures against the protein sequence (eight segments). These signatures mainly represent protein belongs to the same family, functional domains, or active site and can be used to extrapolate the potential function of query protein. 
Interaction study of oseltamivir and zanamivir with the infl uenza A virus (H1N1 1918 and H1N1 2009)
Discussion
The in silico genome study reveals that majority of the mutations are taking place in segment 1 and segment 4 which codes for PB2 and hemagglutinin and only few mutations were found in the segment 6 which codes for neuraminidase (NA). Oseltamivir and Zanamivir (NA inhibitors) are presently used in controlling the present pandemic situation. [8, 9,] and [11] . The resistance occurs due to the changes in the neuraminidase active site which leads to alter the binding pocket of the Oseltamivir, whereas changes accommodate Zanamivir without such an alteration in the binding pocket [12] . In the present study we found that both the drugs Oseltamivir and Zanamivir has good number of interaction and scoring function compare with H1N1 2009 to H1N1 1918. We concluded that Zanamivir and Oseltamivir will be effectively control the present pandemic H1N1 2009.
